medline.ch Onkologie Gynäkologische Tumoren

	The current status of secondary cytoreduction in ovarian cancer: a systematic review. Clin Adv Hematol Oncol Margul D, Coleman RL, Herzog TJ. PMID: 32649655 [PubMed - as supplied by publisher]
	Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer. Pharmacogenet Genomics Ingle JN, Kalari KR, Barman P, Shepherd LE, Ellis MJ, Goss PE, Buzdar AU, Robson ME, Cairns J, Carlson EE, Eyman Casey A, Hoskin TL, Goodnature BA, Haddad TC, Goetz MP, Weinshilboum RM, Wang L. PMID: 32649577 [PubMed - as supplied by publisher]
	PdpaMn inhibits fatty acid synthase-mediated glycolysis by down-regulating PI3K/Akt signaling pathway in breast cancer. Anticancer Drugs Okrah EA, Wang Q, Fu H, Chen Q, Gao J. PMID: 32649369 [PubMed - as supplied by publisher]
	Factors influencing breast cancer awareness: a cross-sectional study in China. J Comp Eff Res Liu N, Li P, Wang J, Guo PP, Zhang XH, Yang S, Yu L, Zhang XM, Zhang W. PMID: 32648473 [PubMed - as supplied by publisher]
	Role of hyperthermic intraperitoneal chemotherapy in ovarian cancer. Chin Clin Oncol Medina-Castro JM, Ruiz-DeLeón A. PMID: 32648446 [PubMed - as supplied by publisher]
	Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database. Breast Cancer Res Treat Du ZL, Wang Y, Wang DY, Zhang L, Bian ZM, Deng Y, Xu CS, Lin DC, Xie L, Jia Y, Gao JD, Zhang BL. PMID: 32647940 [PubMed - as supplied by publisher]
	Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials. Breast Cancer Res Treat Thein KZ, Htut TW, Ball S, Swarup S, Sultan A, Oo TH. PMID: 32647939 [PubMed - as supplied by publisher]
	Incidence and Predictors of Recurrence among Breast Cancer Patients in Black Lion Specialized Hospital Adult Oncology Unit, Addis Ababa, Ethiopia: Retrospective Follow-up Study with Survival Analysis. J Cancer Prev Shiferaw WS, Aynalem YA, Akalu TY, Demelew TM. PMID: 32647652 [PubMed]
	How to know what to know: Information challenges for women in the diagnostic phase of breast cancer. Patient Educ Couns Ormel I, Magalhaes M, Josephson D, Tracey L, Law S. PMID: 32646774 [PubMed - as supplied by publisher]
	A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer. Int J Mol Sci Guadagni S, Clementi M, Masedu F, Fiorentini G, Sarti D, Deraco M, Kusamura S, Papasotiriou I, Apostolou P, Aigner KR, Zavattieri G, Farina AR, Vizzielli G, Scambia G, Mackay AR. PMID: 32646060 [PubMed - in process]
	Exosomal MicroRNAs and Organotropism in Breast Cancer Metastasis. Cancers (Basel) Wong GL, Abu Jalboush S, Lo HW. PMID: 32646059 [PubMed]
	Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches. Int J Mol Sci Zakarya R, Howell VM, Colvin EK. PMID: 32645943 [PubMed - in process]
	Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype. Pathobiology Kariri YA, Aleskandarany MA, Joseph C, Kurozumi S, Mohammed OJ, Toss MS, Green AR, Rakha EA. PMID: 32645698 [PubMed - as supplied by publisher]
	Axillary accessory breast cancer with persistent leftsuperior vena cava: A case report and treatment controversy. Int J Surg Case Rep Zhang J, Zhang W, Min M, Pan Y. PMID: 32645595 [PubMed - as supplied by publisher]
	A prospective study of receptor profiles in breast cancer and the ipsilateral axillary lymph node metastases measured simultaneously in treatment naÃ¯ve cases. S Afr J Surg Mannell A, Nel CE, Smilg JS, Haberfield J, Nietz S, Candy GP. PMID: 32644312 [PubMed - in process]
	Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial. JAMA Oncol Radovich M, Jiang G, Hancock BA, Chitambar C, Nanda R, Falkson C, Lynce FC, Gallagher C, Isaacs C, Blaya M, Paplomata E, Walling R, Daily K, Mahtani R, Thompson MA, Graham R, Cooper ME, Pavlick DC, Albacker LA, Gregg J, Solzak JP, Chen YH, Bales CL, Cantor E, Shen F, Storniolo AMV, Badve S, Ballinger TJ, Chang CL, Zhong Y, Savran C, Miller KD, Schneider BP. PMID: 32644110 [PubMed - as supplied by publisher]
	Feasibility Study of Synthetic Diffusion-Weighted MRI in Patients with Breast Cancer in Comparison with Conventional Diffusion-Weighted MRI. Korean J Radiol Choi BH, Baek HJ, Ha JY, Ryu KH, Moon JI, Park SE, Bae K, Jeon KN, Jung EJ. PMID: 32643330 [PubMed - as supplied by publisher]
	Higher dietary soy intake appears inversely related to breast cancer risk independent of estrogen receptor breast cancer phenotypes. Heliyon Okekunle AP, Gao J, Wu X, Feng R, Sun C. PMID: 32642579 [PubMed]
	A five-year (2015 to 2019) analysis of studies focused on breast cancer prediction using machine learning: A systematic review and bibliometric analysis. J Public Health Res Salod Z, Singh Y. PMID: 32642458 [PubMed]
	Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis. Sci Rep O'Shaughnessy J, Cortes J, Twelves C, Goldstein LJ, Alexis K, Xie R, Barrios C, Ueno T. PMID: 32641747 [PubMed - in process]

Artikel 1 - 20 / 228520

Seite 1 von 11426

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung